Glide Pharma signs a collaborative development programme with an UK government agency. This collaborative programme scheduled to run for a year will enable a feasibility study to evaluate the Glide SDI® technology in the area of bio-defence.
Glide Pharma signs a collaborative development programme with an UK government agency. This collaborative programme scheduled to run for a year will enable a feasibility study to evaluate the Glide SDI® technology in the area of bio-defence.
